Trial Profile

Single-Center, Double-Blind, Placebo-Controlled, Single-Dose, 4-Period Crossover, Drug-Alcohol Interaction Study in Lemborexant in Healthy Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 14 Jun 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lemborexant (Primary) ; Alcohol
Indications Circadian rhythm sleep disorders; Insomnia; Sleep apnoea syndrome
Focus Pharmacodynamics
Sponsors Eisai Inc

Most Recent Events

01 Jun 2022 Results assessing effects of lemborexant and alcohol coadministration on postural stability, cognitive performance, and the pharmacokinetics, safety, and tolerability of lemborexant published in the Journal of Psychopharmacology
16 Oct 2018 Status changed from recruiting to completed.
19 Jul 2018 Planned End Date changed from 18 Jun 2018 to 12 Sep 2018.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com